Immutep Statistics
Total Valuation
Immutep has a market cap or net worth of $39.81 million. The enterprise value is -$8.41 million.
| Market Cap | 39.81M |
| Enterprise Value | -8.41M |
Important Dates
The next estimated earnings date is Friday, October 2, 2026, before market open.
| Earnings Date | Oct 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Immutep has 1.47 billion shares outstanding. The number of shares has increased by 1.08% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.47B |
| Shares Change (YoY) | +1.08% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 3.45% |
| Owned by Institutions (%) | 54.47% |
| Float | 1.40B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.89 |
| Forward PS | 5.27 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.69, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.69 |
| Quick Ratio | 5.54 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,201.71 |
Financial Efficiency
Return on equity (ROE) is -77.31% and return on invested capital (ROIC) is -49.07%.
| Return on Equity (ROE) | -77.31% |
| Return on Assets (ROA) | -42.45% |
| Return on Invested Capital (ROIC) | -49.07% |
| Return on Capital Employed (ROCE) | -118.07% |
| Weighted Average Cost of Capital (WACC) | 16.14% |
| Revenue Per Employee | $444,853 |
| Profits Per Employee | -$1.77M |
| Employee Count | 31 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.77% in the last 52 weeks. The beta is 2.20, so Immutep's price volatility has been higher than the market average.
| Beta (5Y) | 2.20 |
| 52-Week Price Change | -82.77% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 1.20 |
| Relative Strength Index (RSI) | 29.64 |
| Average Volume (20 Days) | 349,643 |
Short Selling Information
The latest short interest is 1.06 million, so 0.74% of the outstanding shares have been sold short.
| Short Interest | 1.06M |
| Short Previous Month | 760,586 |
| Short % of Shares Out | 0.74% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.46 |
Income Statement
In the last 12 months, Immutep had revenue of $13.79 million and -$54.86 million in losses. Loss per share was -$0.04.
| Revenue | 13.79M |
| Gross Profit | -49.82M |
| Operating Income | -56.45M |
| Pretax Income | -54.86M |
| Net Income | -54.86M |
| EBITDA | -54.93M |
| EBIT | -56.45M |
| Loss Per Share | -$0.04 |
Balance Sheet
The company has $47.65 million in cash and $724,681 in debt, with a net cash position of $46.92 million or $0.03 per share.
| Cash & Cash Equivalents | 47.65M |
| Total Debt | 724,681 |
| Net Cash | 46.92M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 42.57M |
| Book Value Per Share | 0.03 |
| Working Capital | 45.98M |
Cash Flow
In the last 12 months, operating cash flow was -$39.56 million and capital expenditures -$66,287, giving a free cash flow of -$39.63 million.
| Operating Cash Flow | -39.56M |
| Capital Expenditures | -66,287 |
| Depreciation & Amortization | 1.56M |
| Net Borrowing | -152,949 |
| Free Cash Flow | -39.63M |
| FCF Per Share | -$0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | -409.31% |
| Pretax Margin | -397.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Immutep does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.08% |
| Shareholder Yield | -1.08% |
| Earnings Yield | -137.81% |
| FCF Yield | -99.54% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | -53.53% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 28, 2016. It was a reverse split with a ratio of 1:3.33.
| Last Split Date | Dec 28, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3.33 |
Scores
Immutep has an Altman Z-Score of -1.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.3 |
| Piotroski F-Score | 3 |